Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 841 AL 855

Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease

Hacker ML, Currie AD, Molinari AL, Turchan M, Millan SM, Heusinkveld LE, Roach J, Konrad PE, Davis TL, Neimat JS, Phibbs FT, Hedera P, Byrne DW, Charles D.

J Parkinsons Dis. 2016;6(1):125-31. doi: 10.3233/JPD-150712.

Programming Deep Brain Stimulation for Parkinson's Disease: The Toronto Western Hospital Algorithms

Picillo M, Lozano AM, Kou N, Puppi Munhoz R, Fasano A.

Brain Stimul. 2016 May-Jun;9(3):425-437. doi: 10.1016/j.brs.2016.02.004. Epub 2016 Feb 12.

PINK1 and FLNA mutations association: A role for atypical parkinsonism?

Degos B, Toussaint A, Lesage S, Brice A, Vidailhet M, Beldjord C, Catala M.

Parkinsonism Relat Disord. 2016 May;26:78-80. doi: 10.1016/j.parkreldis.2016.02.023. Epub 2016 Mar 2.

A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease

Godinho C, Domingos J, Cunha G, Santos AT, Fernandes RM, Abreu D, Gonçalves N, Matthews H, Isaacs T, Duffen J, Al-Jawad A, Larsen F, Serrano A, Weber P, Thoms A, Sollinger S, Graessner H, Maetzler W, Ferreira JJ.

J Neuroeng Rehabil. 2016 Mar 12;13:24. doi: 10.1186/s12984-016-0136-7.

Multiple faces of protein interacting with C kinase 1 (PICK1): Structure, function, and diseases

Li YH, Zhang N, Wang YN, Shen Y, Wang Y.

Neurochem Int. 2016 Sep;98:115-21. doi: 10.1016/j.neuint.2016.03.001. Epub 2016 Mar 9.

Normal Pressure Hydrocephalus and Parkinsonism: Preliminary Data on Neurosurgical and Neurological Treatment

Broggi M, Redaelli V, Tringali G, Restelli F, Romito L, Schiavolin S, Tagliavini F, Broggi G.

World Neurosurg. 2016 Jun;90:348-356. doi: 10.1016/j.wneu.2016.03.004. Epub 2016 Mar 10.

Brain metabolism as a modulator of autophagy in neurodegeneration

Lim Y, Cho H, Kim EK.

Brain Res. 2016 Oct 15;1649(Pt B):158-165. doi: 10.1016/j.brainres.2016.02.049. Epub 2016 Mar 9.

A Systematic Review of the Prevalence of Oropharyngeal Dysphagia in Stroke, Parkinson's Disease, Alzheimer's Disease, Head Injury, and Pneumonia

Takizawa C, Gemmell E, Kenworthy J, Speyer R.

Dysphagia. 2016 Jun;31(3):434-41. doi: 10.1007/s00455-016-9695-9. Epub 2016 Mar 12.

Validated UHPLC-MS/MS method for the simultaneous determination of pramipexole and ropinirole in plasma of patients with Parkinson's disease

Mohamed S, Riva R, Contin M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 1;1017-1018:114-119. doi: 10.1016/j.jchromb.2016.02.041. Epub 2016 Mar 2.

Neurological Disorders

Thakur KT, Albanese E, Giannakopoulos P, Jette N, Linde M, Prince MJ, Steiner TJ, Dua T.

In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 5.

Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions

Iranzo A, Santamaria J, Tolosa E.

Lancet Neurol. 2016 Apr;15(4):405-19. doi: 10.1016/S1474-4422(16)00057-0.

Lipid Raft Alterations in Aged-Associated Neuropathologies

Marin R, Fabelo N, Fernández-Echevarría C, Canerina-Amaro A, Rodríguez-Barreto D, Quinto-Alemany D, Mesa-Herrera F, Díaz M.

Curr Alzheimer Res. 2016;13(9):973-84. doi: 10.2174/1567205013666160314150017.

Sleep in Neurodegenerative Diseases

Iranzo A.

Sleep Med Clin. 2016 Mar;11(1):1-18. doi: 10.1016/j.jsmc.2015.10.011. Epub 2016 Jan 8.

Membrane remodeling and mechanics: Experiments and simulations of α-Synuclein

West A, Brummel BE, Braun AR, Rhoades E, Sachs JN.

Biochim Biophys Acta. 2016 Jul;1858(7 Pt B):1594-609. doi: 10.1016/j.bbamem.2016.03.012. Epub 2016 Mar 10.

Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson's Disease

Jurado-Coronel JC, Avila-Rodriguez M, Capani F, Gonzalez J, Moran VE, Barreto GE.

Curr Pharm Des. 2016;22(10):1305-11. doi: 10.2174/138161282210160304112133.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias